معرفی
Hari Baskar Balasubramanian is a predoctoral researcher at the University of Vienna, Faculty of Life Sciences, Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology. His work focuses on pharmacological interventions in autoimmune diabetes, diabetic kidney disease, and neurovascular aging.
- ÖAW DOC Fellowship 2024
- Ernst Mach Grant-Worldwide 2023
His research spans pharmacology, immunology, and computational biology, with a focus on:
- Blood-brain barrier senescence metabolism
- Targeted delivery of diabetes therapeutics
- Drug-receptor interactions in fibrotic diseases
- Genetic polymorphisms in immune signaling
- Molecular docking of medicinal plant compounds
- Extracellular ATP in autoimmunity
Recent publications emphasize:
- 2025: Endothelial cell metabolic aging signatures
- 2024: Nintedanib's novel targets and GLP-1's immunomodulatory role
- 2023: sCD39/anti-CD3 diabetes reversal and diabetic kidney disease management
Collaborations span diabetes immunology, neuropharmacology, and medicinal chemistry networks.
۰مقاله منتشرشده
